Purchase Order 75N93018P00708

<p>This $30,600.00 Firm Fixed Price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, for HIV infected patient screening, interviewing, and follow-up services. The contract has an ultimate completion date of January 8, 2016 and was awarded on May 8, 2015. This contract is not associated with a set-aside program.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $52,700.00 firm fixed price purchase order to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, to provide HIV patient screening, collection of specimens, and gathering of medical history for 24 pre-determined patients over the period from August 1, 2019 to December 31, 2019. This sole source award was made under the...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization. The $30,600.00 firm fixed-price purchase order is for screening and interviewing 18 HIV-infected patients, including collecting medical history, blood samples, and specimen shipping. The contract does not have a set-aside designation. This award...

This is a $24,924.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of a &quot;HUMAN NK KIT, CAT#19055&quot;, which are likely specialized biological products and research tools to support immunology and infectious disease research initiatives within the Department of Health and Human...

This federal contract award represents a firm fixed price purchase order valued at $32,096 issued by the National Institutes of Health (NIH) for scientific studies. The contract was awarded on November 5, 2003, with an ultimate completion date of September 30, 2004. No set-aside designation was utilized for this procurement. The work is to be performed at 2323 Riverside Drive, Ottawa, Ontario, Canada, indicating that the prime contractor is a Canadian entity. As a civilian agency within the...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...

This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...

This $9,759 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of &quot;Negative Human CD4 Kits&quot;, which are likely specialized biological materials and cell isolation kits to support biomedical research on infectious diseases....

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...